Results 141 to 150 of about 5,869,436 (291)
Photograph of two journalists of the Orange Leader newspaper. The man on the left is J. Cullen Browning, editor and later vice president of the Orange Leader.
core
Preparing to lead in polycrisis: a multi-method process evaluation of HR-driven psychosocial resilience training for leaders. [PDF]
Hersom C, Torre A.
europepmc +1 more source
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu +9 more
wiley +1 more source
Developing Tomorrow's Perioperative Leaders Today: A Comprehensive Leadership Development Program. [PDF]
Angelilli S, Miller-Burke A, Myers H.
europepmc +1 more source
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim +17 more
wiley +1 more source
From motivation to movement: autonomous motivation and physical activity levels among students in the Global Health Program. [PDF]
Ale OJA +6 more
europepmc +1 more source
Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim +11 more
wiley +1 more source
Transcription Regulatory Sequences in Coronaviruses: Mechanistic Foundations for Antivirals and Vaccines. [PDF]
Myoung J.
europepmc +1 more source
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source

